中文版
  • Company news


Investee Company:Grain Meat has successively completed the angel round and the A round of financing

Nov 09, 2021

Grain Meat has successively completed the angel round and the A round of financing, with a cumulative amount of nearly 100 million yuan...

Investee Company:Zhimeng Biopharma announces the closing of $55 million series B financing

Nov 08, 2021

Nov. 8th, 2021, Oceanpine Investee Company——Shanghai Zhimeng Biopharma, Inc. has announced the successful completion of a 55 million series B financing...

Oceanpine Capital Officially Promotes Rachel Yu to Partner

Nov 08, 2021

On November 8, 2021, Oceanpine Capital announces the promotion of Ms. Rachel Yu as a partner of Oceanpine Capital.

Investee Company:Clover Biopharmaceuticals Announces Offer Price and Allotment Results of the Global Offering

Nov 04, 2021

(November 4, 2021-Hong Kong) Clover Biopharmaceuticals, Ltd. (the “Company”; Stock code: 2197.HK) today announced the allotment results of the global offering of the Company (the “Global Offering”)...

Investee Company:ScaleFlux Announces Next Generation Portfolio, Bringing Highly Efficient Computational Storage to the Masses

Nov 04, 2021

SAN JOSE, Calif., Nov. 04, 2021 (GLOBE NEWSWIRE) , Oceanpine Investee Company——ScaleFlux., the leader in deploying Computational Storage at scale, today announced a new suite of products based on its new chip...

Investee Company: Enlight Medica Raises Hundreds of Millions RMB in Series B Round

Oct 18, 2021

a leading company in the development, production and distribution of innovative medical diagnostics and therapeutic devices in China,today announced the the completion of the C round of hundreds of millions RMB in financing,Oceanpine Capital...

Investee Company:Creative Biosciences has raised $87 million in its Series D round

Oct 15, 2021

Chinese early-stage cancer screening solution specialist Creative Biosciences (Guangzhou) Co., Ltd has raised 560 million yuan ($87 million) in its Series D round led by Alibaba...

Investee Company:Immune—onc Evaluating IO-108, a Novel Antagonist Antibody Targeting LILRB2 (ILT4), in Patients With Advanced Solid Tumors

Oct 14, 2021

Investee Company:Immune—onc Evaluating IO-108, a Novel Antagonist Antibody Targeting LILRB2 (ILT4), in Patients With Advanced Solid Tumors...

Oceanpine Capital Appoints Wei Zhu as Venture Partner

Sep 14, 2021

Oceanpine Capital today announced that it has appointed Wei Zhu to the position of Venture Partner...

Investee Company: MingMed has completed raising nearly $50 million in Series A+ round

Sep 13, 2021

MingMed Biotechnology, a startup that develops pharmaceutical products, has completed raising nearly $50 million in its Series A+ round...
123456789